C79.32

Clinical Causes: Metastasis from primary cancers such as lung, breast, or melanoma cancers Cancer cells spread through bloodstream or lymphatic vessels Advanced-stage cancers with widespread dissemination

Key Symptoms: Headaches that worsen over time Seizures or convulsions Neurological deficits such as weakness, numbness, or paralysis Changes in mental status, confusion, or cognitive disturbances Visual disturbances or-eye movement problems Nausea and vomiting, especially in the mornings Altered sensation or difficulty speaking

Diagnosis Path: Diagnosing secondary malignant neoplasm of the cerebral meninges involves a combination of clinical evaluation and imaging techniques. Healthcare providers typically order the following tests: - Magnetic Resonance Imaging (MRI) of the brain with contrast to identify and locate tumors - Computed Tomography (CT) scans for additional visualization - Lumbar puncture (spinal tap) to analyze cerebrospinal fluid for cancer cells - Biopsy procedures may be performed if a lesion is accessible for tissue sampling - Review of the patient's medical history, especially previous cancers, to establish secondary origins The interpretation of these tests helps determine the extent of disease spread and guides management strategies.

Treatment Protocols: Treatment approaches for secondary malignant neoplasm of the cerebral meninges aim to alleviate symptoms, control tumor growth, and improve quality of life. Options include: - **Radiation therapy** to target tumor sites and reduce tumor burden - **Chemotherapy**, which may involve systemic or intrathecal (direct into cerebrospinal fluid) administration - **Steroids** to decrease swelling and relieve neurological pressure - **Palliative care** focusing on symptom management and supportive measures - Participation in clinical trials exploring targeted therapies or novel treatment modalities Since the condition reflects advanced cancer spread, treatment plans are tailored to individual health status and prognosis.